323 related articles for article (PubMed ID: 16308343)
21. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.
Drewe E; Huggins ML; Morgan AG; Cassidy MJ; Powell RJ
Rheumatology (Oxford); 2004 Nov; 43(11):1405-8. PubMed ID: 15316120
[TBL] [Abstract][Full Text] [Related]
22. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
[TBL] [Abstract][Full Text] [Related]
23. A new mutation causing autosomal dominant periodic fever syndrome in a Danish family.
Weyhreter H; Schwartz M; Kristensen TD; Valerius NH; Paerregaard A
J Pediatr; 2003 Feb; 142(2):191-3. PubMed ID: 12584543
[TBL] [Abstract][Full Text] [Related]
24. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
Huggins ML; Radford PM; McIntosh RS; Bainbridge SE; Dickinson P; Draper-Morgan KA; Tighe PJ; Powell RJ; Todd I
Arthritis Rheum; 2004 Aug; 50(8):2651-9. PubMed ID: 15334481
[TBL] [Abstract][Full Text] [Related]
25. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
26. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese.
Horiuchi T; Tsukamoto H; Mitoma H; Miyagawa H; Tamimoto Y; Yoshizawa S; Harada M; Hayashi K; Hashimura C; Oribe M; Okamura S
Int J Mol Med; 2004 Nov; 14(5):813-8. PubMed ID: 15492850
[TBL] [Abstract][Full Text] [Related]
28. Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks.
Dodé C; Hazenberg BP; Pêcheux C; Cattan D; Moulin B; Barthélémy A; Gubler MC; Delpech M; Grateau G
Nephrol Dial Transplant; 2002 Jul; 17(7):1212-7. PubMed ID: 12105243
[TBL] [Abstract][Full Text] [Related]
29. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
Nakamura M; Tokura Y
Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
[No Abstract] [Full Text] [Related]
30. Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.
Sinožić D; Toplak N; Milotić I
J Clin Rheumatol; 2011 Sep; 17(6):325-8. PubMed ID: 21869706
[TBL] [Abstract][Full Text] [Related]
31. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever.
Marek-Yagel D; Berkun Y; Padeh S; Lidar M; Shinar Y; Bar-Joseph I; Reznik-Wolf H; Langevitz P; Livneh A; Pras E
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1294-8. PubMed ID: 20506103
[TBL] [Abstract][Full Text] [Related]
32. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
Nakamura M; Kobayashi M; Tokura Y
Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
[No Abstract] [Full Text] [Related]
33. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
Aganna E; Aksentijevich I; Hitman GA; Kastner DL; Hoepelman AI; Posma FD; Zweers EJ; McDermott MF
Eur J Hum Genet; 2001 Jan; 9(1):63-6. PubMed ID: 11175303
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
[TBL] [Abstract][Full Text] [Related]
36. Low TNF-induced NF-kappaB and p38 phosphorylation levels in leucocytes in tumour necrosis factor receptor-associated periodic syndrome.
Stjernberg-Salmela S; Ranki A; Karenko L; Siitonen S; Mustonen H; Puolakkainen P; Sarna S; Pettersson T; Repo H
Rheumatology (Oxford); 2010 Feb; 49(2):382-90. PubMed ID: 20071450
[TBL] [Abstract][Full Text] [Related]
37. An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q.
McDermott MF; Aganna E; Hitman GA; Ogunkolade BW; Booth DR; Hawkins PN
Arthritis Rheum; 2000 Sep; 43(9):2034-40. PubMed ID: 11014353
[TBL] [Abstract][Full Text] [Related]
38. Overlap syndrome between Familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome in a lupus patient.
Nonaka F; Migita K; Iwasaki K; Shimizu T; Kawakami A; Yasunami M; Eguchi K
Tohoku J Exp Med; 2014 Jun; 233(2):73-7. PubMed ID: 24835548
[TBL] [Abstract][Full Text] [Related]
39. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
[TBL] [Abstract][Full Text] [Related]
40. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
